Ken Griffin's position in Cytokinetics is currently worth $7.13 Million. That's 0.01% of their equity portfolio (1358th largest holding). The first Cytokinetics trade was made in Q1 2014. Since then Ken Griffin bought shares 52 more times and sold shares on 50 occasions. The investor's estimated purchase price is $7.54 Million, resulting in a loss of 5.5%.